Del Sette Capital Management LLC Acquires New Shares in Regeneron Pharmaceuticals, Inc. $REGN

robot
Abstract generation in progress

Del Sette Capital Management LLC has purchased a new position of 2,919 shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) during the fourth quarter, valued at approximately $2.25 million. This investment now constitutes about 1.4% of Del Sette Capital Management LLC’s portfolio. Other institutional investors have also recently adjusted their holdings in REGN, with a significant majority of the stock (83.31%) owned by institutions.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin